FDA expands use of Teva’s Austedo in Parkinson’s
admin 31st August 2017 Uncategorised 0Teva’s Austedo is now the first and only therapy approved in the US to treat both tardive dyskinesia and chorea associated with Huntington’s disease.
More: FDA expands use of Teva’s Austedo in Parkinson’s
Source: News